News
The Canadian Dupuytren Society’s Triennial Objectives
The Canadian Dupuytren Society’s Triennial Objectives underlying fundraising efforts were determined at the General Meeting of Members and the Board of Directors’ meeting of April 27, 2020 and focused on the expansion of the CDS website, funding of research on Dupuytren’s disease, and the exchange of clinical information at professional conferences.
- Triennial objectives of the Canadian Dupuytren Society
- New IT partner Vortex Solution
- New Partnership with IMD Health
The Canadian Dupuytren Society’s Triennial Objectives underlying fundraising efforts were determined at the General Meeting of Members and the Board of Directors’ meeting of April 27, 2020 and focused on the expansion of the CDS website, funding of research on Dupuytren’s disease, and the exchange of clinical information at professional conferences. The details are reproduced below.
As a key strategy for the Web site’s expansion objective, the Society relies on Vortex Solution as an IT partner that could support the growth of the information available on our Web site over the next few years.
In the same vein, the CDS entered into an agreement with IMD Health, a company offering an educational platform of medical information that healthcare professionals can use to inform their patients about the particularities of their conditions. IMD Health will publish the medical information included on the CPC website.
Triennial objectives of the Canadian Dupuytren Society
The fundraising objectives are closely linked to CDS’s organizational goals. Specifically, the Canadian Dupuytren Society’s objective of the next 3 years will focus on:
EXPANDING THE CDS WEBSITE
The CDS website will be expanded to include more information on the disease with an interactive interface, an enhanced engagement of patients and links to Dupuytren healthcare practioners.
FUNDING OF RESEARCH ON THE PREVALENCE OF DD
The prevalence of DD in Canada has only been documented to a limited extent. CDS and the medical community would greatly benefit from comprehensive data to develop advocacy initiatives and to better respond to patient needs.
CLINICAL INFORMATION EXCHANGE AT CONFERENCES
In the absence of universal approaches for treating DD, members of the MAB will be encouraged and supported in their efforts to participate clinical conferences (expert panels, abstracts…) on various specialties such as orthopedic plastic/hand surgery, radio-oncology and rheumatology to help raise awareness of DD with other specialists and explore a variety of treatments.